Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocugen (OCGN) Enterprise Value: 2014-2025

Historic Enterprise Value for Ocugen (OCGN) over the last 12 years, with Sep 2025 value amounting to $476.5 million.

  • Ocugen's Enterprise Value rose 66.82% to $476.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $476.5 million, marking a year-over-year increase of 66.82%. This contributed to the annual value of $234.5 million for FY2024, which is 117.09% up from last year.
  • According to the latest figures from Q3 2025, Ocugen's Enterprise Value is $476.5 million, which was up 68.13% from $283.4 million recorded in Q2 2025.
  • Ocugen's Enterprise Value's 5-year high stood at $1.5 billion during Q2 2021, with a 5-year trough of $49.1 million in Q3 2023.
  • For the 3-year period, Ocugen's Enterprise Value averaged around $232.3 million, with its median value being $234.5 million (2024).
  • Its Enterprise Value has fluctuated over the past 5 years, first skyrocketed by 100,824.59% in 2021, then tumbled by 86.01% in 2023.
  • Ocugen's Enterprise Value (Quarterly) stood at $811.3 million in 2021, then crashed by 76.14% to $193.6 million in 2022, then tumbled by 44.21% to $108.0 million in 2023, then soared by 117.09% to $234.5 million in 2024, then surged by 66.82% to $476.5 million in 2025.
  • Its Enterprise Value stands at $476.5 million for Q3 2025, versus $283.4 million for Q2 2025 and $206.2 million for Q1 2025.